Integra Stock Price Prediction

IART -  USA Stock  

USD 68.72  0.74  1.07%

Integra Lifesciences stock price prediction is an act of determining the future value of Integra Lifesciences shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Integra Lifesciences stock future price could yield a significant profit.
We analyze noise-free headlines and recent hype associated with Integra Lifesciences, which may create opportunities for some arbitrage if properly timed. Please see Integra Lifesciences Basic Forecasting Models to cross-verify your projections.

Search Stock Price Prediction 

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Integra Lifesciences based on different types of headlines from major news networks to social media. The Integra stock price prediction module provides an analysis of price elasticity to changes in media outlook on Integra Lifesciences over a specific investment horizon. Using Integra Lifesciences hype-based prediction, you can estimate the value of Integra Lifesciences from the perspective of Integra Lifesciences response to recently generated media hype and the effects of current headlines on its competitors.
Integra Lifesciences Revenue to Assets are comparatively stable at the moment as compared to the past year. Integra Lifesciences reported Revenue to Assets of 0.38 in 2020. Quick Ratio is likely to gain to 1.83 in 2021, whereas Operating Margin is likely to drop 10.29 in 2021.
This module is based on analyzing investor sentiment around taking a position in Integra Lifesciences. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Integra Lifesciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Integra because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Integra Lifesciences after-hype prediction price

    
  $ 68.69  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Integra Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Integra Lifesciences in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
63.5664.9375.59
Details
Naive
Forecast
LowNext ValueHigh
67.6168.9870.35
Details
7 Analysts
Consensus
LowTarget PriceHigh
53.0073.1288.00
Details
Earnings
Estimates (2)
LowProjected EPSHigh
2.922.922.93
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Integra Lifesciences. Your research has to be compared to or analyzed against Integra Lifesciences' peers to derive any actionable benefits. When done correctly, Integra Lifesciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Integra Lifesciences.

Integra Lifesciences After-Hype Price Prediction Density Analysis

As far as predicting the price of Integra Lifesciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Integra Lifesciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Integra Lifesciences, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Integra Lifesciences Estimiated After-Hype Price Volatility

In the context of predicting Integra Lifesciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Integra Lifesciences' historical news coverage. Integra Lifesciences' after-hype downside and upside margins for the prediction period are 67.32 and 70.06, respectively. We have considered Integra Lifesciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
68.72
20th of June 2021
68.69
After-hype Price
70.06
Upside
Integra Lifesciences is very steady asset. Analysis and calculation of next after-hype price of Integra Lifesciences is based on 3 months time horizon.

Integra Lifesciences Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Integra Lifesciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Integra Lifesciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Integra Lifesciences, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.05  1.37  0.03   0.00  10 Events / Month5 Events / MonthIn about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
68.7268.690.04 
240.35  

Integra Lifesciences Hype Timeline

Integra Lifesciences is currently traded for 68.72. The entity has historical hype elasticity of -0.03 and average elasticity to hype of competition of 0.0. Integra is projected to decline in value after the next headline with price expected to drop to 68.69. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -0.04% whereas the daily expected return is currently at 0.05%. The volatility of related hype on Integra Lifesciences is about 1.37E7% with expected price after next announcement by competition of 68.72. About 14.0% of the company shares are held by company insiders. The book value of Integra Lifesciences was currently reported as 18.1. The company has Price/Earnings To Growth (PEG) ratio of 1.32. Integra Lifesciences had not issued any dividends in recent years. The entity had 1106:1000 split on the 4th of January 2017. Given the investment horizon of 90 days the next projectedpress releasewill be in about 10 days.
Please see Integra Lifesciences Basic Forecasting Models to cross-verify your projections.

Integra Lifesciences Related Hype Analysis

Having access to credible news sources related to Integra Lifesciences' direct competition is more important than ever and may enhance your ability to predict Integra Lifesciences' future price movements. Getting to know how Integra Lifesciences rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Integra Lifesciences may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
Edwards Lifesciences Corp 0.27 10 per month 0.86  0.24  2.17 (1.83)  8.54 
Dynatronics Cp 0.04 12 per month 0.00 (0.0417)  5.56 (6.82)  16.95 
Encision 0.01 1 per month 4.32  0.12  15.00 (10.75)  41.31 
Echo Therapeutics 0.0001 1 per month 0.00 (0.0108)  39.74 (33.71)  152.19 
Edap Tms Sa(0.01) 2 per month 0.00 (0.09)  5.32 (6.28)  31.67 
Electromed(0.54) 1 per month 0.00 (0.019)  4.85 (5.05)  19.47 
Escalon Med Cp 0.01 10 per month 8.39  0.0247  27.78 (16.13)  70.48 
Establishment Labs Holdings 0.94 1 per month 3.07  0.13  5.71 (4.74)  13.51 
Second Sight 0.38 2 per month 0.00 (0.10)  15.62 (11.66)  47.04 
Abbott Laboratories(1.10) 8 per month 0.00 (0.06)  2.01 (2.03)  11.85 

Integra Lifesciences Additional Predictive Modules

Most predictive techniques to examine Integra price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Integra using various technical indicators. When you analyze Integra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Integra Lifesciences Predictive Indicators

The successful prediction of Integra Lifesciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Integra Lifesciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Integra Lifesciences based on analysis of Integra Lifesciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Integra Lifesciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Integra Lifesciences's related companies.
 2018 2019 (projected)
Long Term Debt to Equity0.970.92
Interest Coverage1.792.17

Story Coverage note for Integra Lifesciences

The number of cover stories for Integra Lifesciences depends on current market conditions and Integra Lifesciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Integra Lifesciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Integra Lifesciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Contributor Headline

Latest Perspective on Integra Lifesciences

Integra Lifesciences Short Properties

Integra Lifesciences' future price predictability will typically decrease when Integra Lifesciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Integra Lifesciences often depends not only on the future outlook of the potential Integra Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Integra Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out4.50%
Short Percent Of Float6.09%
Float Shares72.74M
Average Daily Volume Last 10 Day296.18k
Shares Short Prior Month3.63M
Average Daily Volume In Three Month361.17k
Date Short Interest30th of April 2021
Please see Integra Lifesciences Basic Forecasting Models to cross-verify your projections. Note that the Integra Lifesciences information on this page should be used as a complementary analysis to other Integra Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Integra Lifesciences Stock analysis

When running Integra Lifesciences price analysis, check to measure Integra Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra Lifesciences is operating at the current time. Most of Integra Lifesciences' value examination focuses on studying past and present price action to predict the probability of Integra Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Integra Lifesciences' price. Additionally, you may evaluate how the addition of Integra Lifesciences to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
The market value of Integra Lifesciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Integra Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra Lifesciences' market value can be influenced by many factors that don't directly affect Integra Lifesciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Integra Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.